| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 2.841 | 10.647 | 34.845 | 59.593 | 85.842 | 104.658 |
| Total Income - EUR | - | - | - | - | 2.841 | 10.647 | 34.846 | 59.594 | 85.848 | 104.727 |
| Total Expenses - EUR | - | - | - | - | 683 | 2.518 | 23.977 | 39.794 | 48.454 | 60.749 |
| Gross Profit/Loss - EUR | - | - | - | - | 2.158 | 8.129 | 10.869 | 19.800 | 37.394 | 43.977 |
| Net Profit/Loss - EUR | - | - | - | - | 2.073 | 7.825 | 10.514 | 19.294 | 36.664 | 41.307 |
| Employees | - | - | - | - | 0 | 0 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Sferlemed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 41.972 | 32.196 | 22.222 | 12.839 |
| Current Assets | - | - | - | - | 2.849 | 10.143 | 9.498 | 23.485 | 43.770 | 81.575 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 843 | 930 | 3.710 | 4.110 | 13.904 | 708 |
| Cash | - | - | - | - | 2.006 | 9.213 | 5.788 | 19.375 | 29.867 | 80.867 |
| Shareholders Funds | - | - | - | - | 2.115 | 9.900 | 20.195 | 33.346 | 57.239 | 90.272 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 734 | 243 | 31.276 | 22.335 | 17.654 | 4.142 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sferlemed S.r.l.